Qilian International Holding Group LTD Sample Contracts
QILIAN INTERNATIONAL HOLDING GROUP LIMITED (the “Issuer”) AND [TRUSTEE] (the “Trustee”) INDENTURE Dated as of [●], 2024 Senior Debt SecuritiesIndenture • April 10th, 2024 • Qilian International Holding Group LTD • Pharmaceutical preparations • New York
INDENTURE, dated as of [●], 2024, among QILIAN INTERNATIONAL HOLDING GROUP LIMITED, a Cayman Islands corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations • New York
This Indemnification Agreement (this “Agreement”) is entered into as of by and between Qilian International Holding Group Limited, a Cayman Islands company (the “Company”), and the undersigned, a director and/or an officer of the Company (“Indemnitee”), as applicable.
EMPLOYMENT AGREEMENTEmployment Agreement • June 4th, 2024 • Qilian International Holding Group LTD • Pharmaceutical preparations
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of May 30, 2024 (the “Effective Date”), by and between Qilian International Holding Group Limited, incorporated under the laws of the Cayman Islands (the “Company”), and Yaxuan Zhai, an individual (the “Chief Financial Officer (CFO)”). Except with respect to the direct employment of the CFO by the Company, the term “Company” as used herein with respect to all obligations of the CFO hereunder shall be deemed to include the Company and all of its subsidiaries and affiliated entities (collectively, the “Group”).
QILIAN INTERNATIONAL HOLDING GROUP LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • December 23rd, 2020 • Qilian International Holding Group LTD • Pharmaceutical preparations • New York
EMPLOYMENT AGREEMENTEmployment Agreement • June 4th, 2024 • Qilian International Holding Group LTD • Pharmaceutical preparations
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of May 30, 2024 (the “Effective Date”), by and between Qilian International Holding Group Limited, incorporated under the laws of the Cayman Islands (the “Company”), and Chen Xin, an individual (the “Chief Executive Officer (CEO)”). Except with respect to the direct employment of the CEO by the Company, the term “Company” as used herein with respect to all obligations of the CEO hereunder shall be deemed to include the Company and all of its subsidiaries and affiliated entities (collectively, the “Group”).
Agricultural Bank of China Co., Ltd Working Capital Loan Contract No.:62010120200000188Working Capital Loan Contract • April 8th, 2020 • Qilian International Holding Group LTD • Pharmaceutical preparations
According to the applicable Chinese laws and regulations, both parties hereby enter into this contract through consultations.
TRANSACTION AGREEMENTTransaction Agreement • May 28th, 2025 • BGM Group Ltd. • Pharmaceutical preparations • Hong Kong
This TRANSACTION AGREEMENT (as may be amended, restated, supplemented or varied in accordance with the terms herein, this “Agreement”) is entered into and effective as of May 27, 2025, by and among:
EQUITY PLEDGE AGREEMENT ON GANSU QILIANSHAN PHARMACEUTICAL CO., LTD. AMONG [Shareholder’s Name] AND CHENGDU QILIAN TRADING CO., LTD. May 20, 2019 EQUITY PLEDGE AGREEMENTEquity Pledge Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations
This EQUITY PLEDGE AGREEMENT (hereinafter, this "AGREEMENT") is entered into as of May 20, 2019 (“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
THE AMENDED EXCLUSIVE SERVICE AGREEMENT AMONG CHENGDU QILIAN TRADING CO., LTD AND GANSU QILIANSHAN PHARMECEUTICAL CO., LTD. August 27, 2019 THE AMENDED EXCLUSIVE SERVICE AGREEMENTExclusive Service Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations
This AMENDED EXCLUSIVE SERVICE AGREEMENT (this “AGREEMENT”) is entered into as of August 27, 2019(“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
CALL OPTION AGREEMENT ON GANSU QILIANSHAN PHARMACEUTICAL CO., LTD. AMONG [Shareholder’s Name] AND CHENGDU QILIAN TRADING CO., LTD. [Date]Call Option Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations
This CALL OPTION AGREEMENT (this “AGREEMENT”) is entered into as of 【 , 2019】(“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
SHARE SUBSCRIPTION AGREEMENTShare Subscription Agreement • November 27th, 2024 • BGM Group Ltd. • Pharmaceutical preparations • Hong Kong
SHAREHOLDERS’ VOTING RIGHTS PROXY AGREEMENT ON GANSU QILIANSHAN PHARMACEUTICAL CO., LTD. AMONG [Shareholder’s Name] AND CHENGDU QILIAN TRADING CO., LTD. [Date] SHAREHOLDERS’ VOTING RIGHTS PROXY AGREEMENTShareholder Agreement • November 4th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations
This SHAREHOLDERS’ VOTING RIGHTS PROXY AGREEMENT (this “AGREEMENT”) is entered into as of [Date] (“SIGNING DATE”) in [City], the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
Investment AgreementInvestment Agreement • February 11th, 2022 • Qilian International Holding Group LTD • Pharmaceutical preparations
After friendly and equal consultation, both party a and party b to party b voluntarily in model. flood-control of high-tech investment construction pig by-products deep processing projects, according to the law of the People's Republic of China civil code, the land administration law of the People's Republic of China and other laws and regulations of the relevant regulations, in line with the principle of equality, voluntariness, honesty and credit to conclude the following contract.
EXCLUSIVE SERVICE SUPPLEMENTARY AGREEMENT AMENDMENTExclusive Service Supplementary Agreement • February 11th, 2022 • Qilian International Holding Group LTD • Pharmaceutical preparations
This EXCLUSIVE SERVICE SUPPLEMENTARY AGREEMENT AMENDMENT (this “ SUPPLEMENT AGREEMENT AMENDMENT”) is entered into as of February 25, 2021 (“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 18th, 2026 • BGM Group Ltd. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 15, 2026 between BGM Group Ltd, a Cayman Islands Company (the “Company”), and investors as listed in the Exhibit I (in aggregate the “Purchasers” and individually the “Purchaser”).
Loan contract Lanyin loan No. 102192020000015 of 2020 Bank of Lanzhou Limited by Share LtdLoan Agreement • June 12th, 2020 • Qilian International Holding Group LTD • Pharmaceutical preparations
This Contract is hereby entered into by and between the Borrower and the Lender through equal and voluntary consultation as to the issue of lending to the Borrower.
ACTING IN CONCERT AGREEMENTActing in Concert Agreement • August 14th, 2025 • BGM Group Ltd. • Pharmaceutical preparations • Hong Kong
Each of the parties above is referred to herein individually as a "Party". Party A, Party A's Holding Company, Party B and Party B's Holding Company are referred to herein collectively as the "Parties."
THE EXCLUSIVE SERVICE AGREEMENT BETWEEN QILIAN SHAN INTERNATIONAL TRADE (HAINAN) CO., LTD AND GANSU QILIANSHAN PHARMECEUTICAL CO., LTD. December 1, 2022Exclusive Service Agreement • December 7th, 2022 • Qilian International Holding Group LTD • Pharmaceutical preparations
This EXCLUSIVE SERVICE AGREEMENT (this “AGREEMENT”) is entered into as of December 1, 2022 (“SIGNING DATE”) in Jiuquan City, the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
WARRANT TO PURCHASE CLASS A ORDINARY SHARE BGM GROUP LTDWarrant Agreement • May 18th, 2026 • BGM Group Ltd. • Pharmaceutical preparations
THIS WARRANT TO PURCHASE CLASS A ORDINARY SHARE (the “Warrant”) certifies that, for value received, investors as listed in the Exhibit I or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the ninety (90th) day following the Closing Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five-year anniversary of the Initial Exercise Date (the “Termination Date”), but not thereafter, to subscribe for and purchase from BGM Group Ltd., a Cayman Islands company (the “Company”), up to 200,000,000 shares of Class A ordinary shares of the Company, par value $0.00833335 per share (the “Class A Ordinary Share”) (as subject to adjustment hereunder, the “Warrant Shares”). This Warrant is one of the Warrants to purchase Class A Ordinary Share (the “Warrants”) issued pursuant to that certain Securities Purchase Agreement, dated as of May 15, 2026 (th
Strain Reconstruction Framework Cooperation AgreementFramework Cooperation Agreement • September 9th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations
On the principle of equality and mutual benefit, both parties have signed this agreement with the aim of transforming Streptomyces rimosus. and improving their production efficiency through mutation, and both parties abide by and fulfill their obligations.
TRANSACTION AGREEMENTTransaction Agreement • May 6th, 2025 • BGM Group Ltd. • Pharmaceutical preparations • Hong Kong
SHAREHOLDERS’ VOTING RIGHTS PROXY AGREEMENT ON GANSU QILIANSHAN PHARMACEUTICAL CO., LTD. AMONG [Shareholder’s Name] AND CHENGDU QILIAN TRADING CO., LTD. [Date] SHAREHOLDERS’ VOTING RIGHTS PROXY AGREEMENTShareholders' Voting Rights Proxy Agreement • June 17th, 2019 • Qilian International Holding Group LTD • Pharmaceutical preparations
This SHAREHOLDERS’ VOTING RIGHTS PROXY AGREEMENT (this “AGREEMENT”) is entered into as of [Date] (“SIGNING DATE”) in [City], the People’s Republic of China (“CHINA” or “PRC”) by and among the following Parties:
contract Corresponding entrustment contract number:_________________________Lease Agreement • August 21st, 2020 • Qilian International Holding Group LTD • Pharmaceutical preparations
In accordance with the provisions of the Contract Law of the People's Republic of China and other laws and regulations, A and B, after friendly consultation and on the principle of equality and mutual benefit,
AGREEMENT TO TERMINATE THE VIE SERVICE AGREEMENTTermination Agreement • December 7th, 2022 • Qilian International Holding Group LTD • Pharmaceutical preparations
This Termination Agreement is entered as of December 1, 2022 ("Effective Date") in Jiuquan City, the People’s Republic of China (“China” or “PRC”) by and between the following Parties: